Times Pakistan
Daily News & Headlines

Govt issues administration guidelines for usage of CanSIno COVID-19 vaccine

The National Command and Operation Centre (NCOC) issued guidelines on Tuesday regarding safe usage of the Chinese single-dose CanSin. 

As per guidelines, the CanSino vaccine will be administered to people over 18 years of age. Citizens under 18 years of age won’t be administered the single-dose CanSino COVID-19 vaccine

The NCOC has recommended that people suffering from fever and currently Covid positive should not be administered the AstraZeneca vaccine.

Who should not receive Vaccine Individuals having fever at the time of coming for vaccination (Can be rescheduled after the illness is settled) Patients with active COVID-19 Those with mild COVID-19 can receive the vaccine once the isolation period is complete. Those with severe COVID-19 can receive the vaccine once they become stable Individuals on short-term immunosuppressive medication should wait for 28 day after themedication ends. Those chronically immunosuppressed may receive the vaccine, though efficacy may be lower That post-transplantation may receive the vaccine 3 months after transplantation That post-chemotherapy may receive the vaccine 28 days after chemotherapy Those having severe and/or uncontrolled cardiovascular disease, respiratory disease, gastrointestinal disease, liver disease, renal disease, endocrine disorder and neurological illness.

Vaccine Storage

Storage and transportation in refrigerated (2-8oC) condition

Do not freeze the vaccine in any circumstance Protect the vaccine from direct exposure to sunlight

Vaccine Administration

Route of Administration: Intramuscular Site of Administration: Lateral Deltoid Muscle (Upper Arm), Non-dominant side Dose: 0.5ml/vial Presentation: Single-dose Regimen: Single shot

Federal Minister for Planning, Development, Reforms and Special Initiatives Asad Umar had said last week that Pakistan will receive 4 million doses of China’s CanSino vaccine by the end of April.

Leave a comment